Kurt Newman, MD’78, is president and chief executive officer of Children’s National Hospital. During his 11 years as CEO, the hospital soared from No. 18 to No. 5 in the nation in U.S. News & World Report’s Best Children’s Hospital annual rankings, with neonatology maintaining the No. 1 spot for six consecutive years. 

Mary Louise Markert, PhD’81, MD'82, HS’82-’84, ’84-’87, is professor emeritus of pediatrics in the Division of Allergy and Immunology and professor emeritus of immunology at Duke University School of Medicine.

Robert J. Lefkowitz, MD is the Chancellor’s Distinguished Professor of Medicine and a professor of biochemistry, pathology, and chemistry at Duke University School of Medicine. He is also a basic research cardiologist at the Duke Heart Center and a member of the Duke Cancer Institute. He has been a Howard Hughes Medical Institute investigator since 1976 and has spent most of his 50-year research career at Duke.

Shelley Hwang, MD, MPH, is the Mary and Deryl Hart Professor of Surgery, vice chair of research of surgery, professor of radiology, and disease group leader of the Breast Cancer Program at the Duke Cancer Institute.

Kevin O. Saunders, PhD’10, is an associate professor in surgery, molecular genetics and microbiology, and in immunology. He is the faculty chairperson for the Diversity, Equity & Inclusion Committee and associate director of the Duke Human Vaccine Institute (DHVI).

Kanecia Zimmerman, MD’07, HS’07-’11, 12-’15, PhD, MPH, is an associate professor of pediatrics in the Division of Critical Care Medicine in the Department of Pediatrics at Duke University School of Medicine.

A diverse team of Duke faculty and community advocates created LATIN-19 (Latinx Advocacy Team and Interdisciplinary Network for COVID-19) in March 2020 to advocate for and bring awareness to the needs of the Latinx community in North Carolina during the COVID-19 crisis.

The Class of 2024 White Coat Ceremony marked a milestone for the students who have finished the didactic portion of the program and set out to begin a year of clinical experiences before graduating next May.

MD/PhD student Christopher Behrer's research examines how to regulate pharmaceutical quality.

Three faculty selected as members of the 2023-2024 class of fellows for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program and the parallel Executive Leadership in Health Care Program.